细胞癌-话题@MedSci

#细胞癌#

1086篇内容 | 2788人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1978934, encodeId=031f19e8934ad, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=英国NICE拒绝将PD-1单抗Keytruda，用于转移或复发的头颈部鳞状细胞癌, objectType=article, longId=186378, objectId=17ce1863e8ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17ce1863e8ed, replyNumber=0, likeNumber=106, createdTime=2020-04-01, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17ce1863e8ed, moduleTitle=英国NICE拒绝将PD-1单抗Keytruda，用于转移或复发的头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17ce1863e8ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978953, encodeId=374219e895336, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=喜大普奔！纳武利尤单抗联合伊匹木单抗双免疫疗法惠及肝细胞癌患者，客观缓解率达33%, objectType=article, longId=189909, objectId=76111899099c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76111899099c, replyNumber=0, likeNumber=158, createdTime=2020-11-02, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76111899099c, moduleTitle=喜大普奔！纳武利尤单抗联合伊匹木单抗双免疫疗法惠及肝细胞癌患者，客观缓解率达33%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76111899099c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978937, encodeId=df9a19e89377e, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Modern Pathology：反极性乳头状肾细胞癌中鉴定了复发性KRAS突变, objectType=article, longId=186807, objectId=d11a18680eac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d11a18680eac, replyNumber=0, likeNumber=92, createdTime=2020-03-12, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d11a18680eac, moduleTitle=Modern Pathology：反极性乳头状肾细胞癌中鉴定了复发性KRAS突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d11a18680eac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979009, encodeId=b2a019e9009fb, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Lancet oncol：Debio 1143治疗局部晚期头颈部鳞状细胞癌, objectType=article, longId=198710, objectId=a8d7198e10e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8d7198e10e3, replyNumber=0, likeNumber=89, createdTime=2021-03-06, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8d7198e10e3, moduleTitle=Lancet oncol：Debio 1143治疗局部晚期头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8d7198e10e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978945, encodeId=09a719e894519, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=FDA批准CMN-001治疗晚期转移性肾细胞癌的IND, objectType=article, longId=188492, objectId=cfd518849273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfd518849273, replyNumber=0, likeNumber=65, createdTime=2020-04-11, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfd518849273, moduleTitle=FDA批准CMN-001治疗晚期转移性肾细胞癌的IND, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfd518849273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978992, encodeId=1c7919e89923a, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=ASCO 2020：K药联合仑伐替尼的“可乐组合”在肾透明细胞癌再显威, objectType=article, longId=195028, objectId=3b871950281b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b871950281b, replyNumber=0, likeNumber=92, createdTime=2021-03-27, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b871950281b, moduleTitle=ASCO 2020：K药联合仑伐替尼的“可乐组合”在肾透明细胞癌再显威, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b871950281b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979045, encodeId=3c2919e9045fa, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Sci Rep：线粒体自噬相关基因PINK1和PARK2是乳头状肾细胞癌生存的独立预后标志物, objectType=article, longId=203395, objectId=7a2a2033959d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a2a2033959d, replyNumber=0, likeNumber=56, createdTime=2021-03-25, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a2a2033959d, moduleTitle=Sci Rep：线粒体自噬相关基因PINK1和PARK2是乳头状肾细胞癌生存的独立预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a2a2033959d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978946, encodeId=cd2319e8946cd, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=J Hepatology： IL-17在脂肪性肝细胞和巨噬细胞中促进酒精相关性肝病中的肝细胞癌的发生, objectType=article, longId=188602, objectId=0572188602fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0572188602fa, replyNumber=0, likeNumber=59, createdTime=2020-12-29, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0572188602fa, moduleTitle=J Hepatology： IL-17在脂肪性肝细胞和巨噬细胞中促进酒精相关性肝病中的肝细胞癌的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0572188602fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979003, encodeId=abe619e90037a, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=AP&T:免疫耐受期慢性乙型肝炎患者发生肝细胞癌的风险极低, objectType=article, longId=197180, objectId=5d3919e180a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d3919e180a1, replyNumber=0, likeNumber=62, createdTime=2020-10-24, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d3919e180a1, moduleTitle=AP&T:免疫耐受期慢性乙型肝炎患者发生肝细胞癌的风险极低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d3919e180a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978943, encodeId=e09719e89431b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Opdivo联合Yervoy用于先前未治疗的晚期或转移性肾细胞癌患者，在42个月的随访中证明了持续的生存益处, objectType=article, longId=188272, objectId=6dff1882e2d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dff1882e2d8, replyNumber=0, likeNumber=52, createdTime=2020-04-09, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dff1882e2d8, moduleTitle=Opdivo联合Yervoy用于先前未治疗的晚期或转移性肾细胞癌患者，在42个月的随访中证明了持续的生存益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6dff1882e2d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978936, encodeId=928619e8936bd, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=晚期肝细胞癌：Cabozantinib、Nivolumab和Ipilimumab的三联疗法具有显著优势, objectType=article, longId=186743, objectId=96bb186e4389, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96bb186e4389, replyNumber=0, likeNumber=138, createdTime=2020-07-04, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96bb186e4389, moduleTitle=晚期肝细胞癌：Cabozantinib、Nivolumab和Ipilimumab的三联疗法具有显著优势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96bb186e4389)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979030, encodeId=906c19e9030cf, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Hepatology：他汀类药物可以降低乙肝患者肝细胞癌的风险, objectType=article, longId=201799, objectId=8b5a201e9922, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b5a201e9922, replyNumber=0, likeNumber=75, createdTime=2021-06-20, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b5a201e9922, moduleTitle=Hepatology：他汀类药物可以降低乙肝患者肝细胞癌的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b5a201e9922)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979029, encodeId=d04119e902963, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Br J Cancer：CRISPR/Cas9全基因组功能丧失筛选技术鉴定法尼基蛋白转移酶参与肾细胞癌的舒尼替尼耐药性, objectType=article, longId=201704, objectId=45e8201e0416, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45e8201e0416, replyNumber=0, likeNumber=107, createdTime=2020-10-15, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45e8201e0416, moduleTitle=Br J Cancer：CRISPR/Cas9全基因组功能丧失筛选技术鉴定法尼基蛋白转移酶参与肾细胞癌的舒尼替尼耐药性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45e8201e0416)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978955, encodeId=04d119e895590, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Biosci Rep：肝细胞癌患者半肝切除术后肝再生和肝切除术后肝功能衰竭的评估, objectType=article, longId=190317, objectId=1ec519031e0e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ec519031e0e, replyNumber=0, likeNumber=63, createdTime=2020-09-16, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ec519031e0e, moduleTitle=Biosci Rep：肝细胞癌患者半肝切除术后肝再生和肝切除术后肝功能衰竭的评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ec519031e0e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978972, encodeId=eb0419e897280, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=赛诺菲/再生元的PD-1单抗Libtayo在基底细胞癌中显示出明显益处, objectType=article, longId=193623, objectId=35ce1936233b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35ce1936233b, replyNumber=0, likeNumber=92, createdTime=2020-11-25, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35ce1936233b, moduleTitle=赛诺菲/再生元的PD-1单抗Libtayo在基底细胞癌中显示出明显益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35ce1936233b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978974, encodeId=534f19e897451, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=抗肿瘤候选植物药“YIV-906”与索拉非尼联合治疗肝细胞癌的IIb期临床试验正式启动, objectType=article, longId=193667, objectId=9ff219366ee3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ff219366ee3, replyNumber=0, likeNumber=77, createdTime=2020-12-28, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ff219366ee3, moduleTitle=抗肿瘤候选植物药“YIV-906”与索拉非尼联合治疗肝细胞癌的IIb期临床试验正式启动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ff219366ee3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979012, encodeId=7ec019e901297, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Hepatology：25-羟维生素D的血清的生物利用度而不是总水平与肝细胞癌的生存率有关, objectType=article, longId=199285, objectId=c4dd1992857b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4dd1992857b, replyNumber=0, likeNumber=67, createdTime=2021-03-10, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4dd1992857b, moduleTitle=Hepatology：25-羟维生素D的血清的生物利用度而不是总水平与肝细胞癌的生存率有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4dd1992857b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979023, encodeId=0fd919e902350, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Br J Cancer：III期临床试验：选择性淋巴结照射和或厄洛替尼联合放化疗改善局部晚期食道鳞状细胞癌患者长期生存率, objectType=article, longId=201182, objectId=099320118291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=099320118291, replyNumber=0, likeNumber=72, createdTime=2021-03-08, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=099320118291, moduleTitle=Br J Cancer：III期临床试验：选择性淋巴结照射和或厄洛替尼联合放化疗改善局部晚期食道鳞状细胞癌患者长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=099320118291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979027, encodeId=ff8819e902766, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=【盘点】近期肾细胞癌研究, objectType=article, longId=201436, objectId=124c20143636, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=124c20143636, replyNumber=0, likeNumber=83, createdTime=2020-11-08, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=124c20143636, moduleTitle=【盘点】近期肾细胞癌研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=124c20143636)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1978951, encodeId=386e19e8951e8, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=NEJM：阿司匹林与肝细胞癌和肝相关死亡率的关系 , objectType=article, longId=189896, objectId=9c2118989605, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c2118989605, replyNumber=0, likeNumber=50, createdTime=2020-09-09, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c2118989605, moduleTitle=NEJM：阿司匹林与肝细胞癌和肝相关死亡率的关系 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c2118989605)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞癌

2020-05-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

英国NICE拒绝将PD-1单抗Keytruda，用于转移或复发的头颈部鳞状细胞癌

2020-04-01

qingting (审核中...)

前往app查看评论内容

#细胞癌#

喜大普奔！纳武利尤单抗联合伊匹木单抗双免疫疗法惠及肝细胞癌患者，客观缓解率达33%

2020-11-02

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Modern Pathology：反极性乳头状肾细胞癌中鉴定了复发性KRAS突变

2020-03-12

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Lancet oncol：Debio 1143治疗局部晚期头颈部鳞状细胞癌

2021-03-06

qingting (审核中...)

前往app查看评论内容

#细胞癌#

FDA批准CMN-001治疗晚期转移性肾细胞癌的IND

2020-04-11

qingting (审核中...)

前往app查看评论内容

#细胞癌#

ASCO 2020：K药联合仑伐替尼的“可乐组合”在肾透明细胞癌再显威

2021-03-27

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Sci Rep：线粒体自噬相关基因PINK1和PARK2是乳头状肾细胞癌生存的独立预后标志物

2021-03-25

qingting (审核中...)

前往app查看评论内容

#细胞癌#

J Hepatology： IL-17在脂肪性肝细胞和巨噬细胞中促进酒精相关性肝病中的肝细胞癌的发生

2020-12-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

AP&T:免疫耐受期慢性乙型肝炎患者发生肝细胞癌的风险极低

2020-10-24

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Opdivo联合Yervoy用于先前未治疗的晚期或转移性肾细胞癌患者，在42个月的随访中证明了持续的生存益处

2020-04-09

qingting (审核中...)

前往app查看评论内容

#细胞癌#

晚期肝细胞癌：Cabozantinib、Nivolumab和Ipilimumab的三联疗法具有显著优势

2020-07-04

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Hepatology：他汀类药物可以降低乙肝患者肝细胞癌的风险

2021-06-20

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Br J Cancer：CRISPR/Cas9全基因组功能丧失筛选技术鉴定法尼基蛋白转移酶参与肾细胞癌的舒尼替尼耐药性

2020-10-15

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Biosci Rep：肝细胞癌患者半肝切除术后肝再生和肝切除术后肝功能衰竭的评估

2020-09-16

qingting (审核中...)

前往app查看评论内容

#细胞癌#

赛诺菲/再生元的PD-1单抗Libtayo在基底细胞癌中显示出明显益处

2020-11-25

qingting (审核中...)

前往app查看评论内容

#细胞癌#

抗肿瘤候选植物药“YIV-906”与索拉非尼联合治疗肝细胞癌的IIb期临床试验正式启动

2020-12-28

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Hepatology：25-羟维生素D的血清的生物利用度而不是总水平与肝细胞癌的生存率有关

2021-03-10

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Br J Cancer：III期临床试验：选择性淋巴结照射和或厄洛替尼联合放化疗改善局部晚期食道鳞状细胞癌患者长期生存率

2021-03-08

qingting (审核中...)

前往app查看评论内容

#细胞癌#

【盘点】近期肾细胞癌研究

2020-11-08

qingting (审核中...)

前往app查看评论内容

#细胞癌#

NEJM：阿司匹林与肝细胞癌和肝相关死亡率的关系

2020-09-09

科室
- - 订阅+
  - 更多科室
工具
服务